Eli Lilly 's CEO David Ricks told Reuters on Wednesday that the U.S. drugmaker expects to launch its obesity drug in Indian market as early as next year.
A rival's weight-loss drug candidate did well in a mid-stage clinical trial. The treatment met all of its endpoints in the study.
The Investment Committee debates how to trade these names: Netflix, Eli Lilly, General Electric and Snowflake.
'Mad Money' host Jim Cramer looks at the current class of $1 trillion stocks and looks at what stocks could be poised to join the group.
Jared Holz, Mizuho, joins 'Fast Money' to talk obesity drugmakers after a new study out of Zealand Pharma analyzed the impact of GLP-1s on liver disease.
Investors learned an important lesson in 2023: investing in the biggest companies and their stocks is a surefire way to capture strong gains. The Magnificent 7 – all of which are trillion dollar sto
Pharma stocks and massive potential are synonymous. With horrible diseases like cancer, diabetes, and heart disease still a mile away from developing a cure, drugs that address these conditions comman
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zealand Pharma's Phase 2 trial was an "uniquivocal win" for a drug that can treat both liver disease and obesity, analysts said.
Eli Lilly's sales and profits are likely to be boosted by new treatments for diabetes, weight loss, and potentially Alzheimer's. The stock's valuation is pricey, but it could look cheap years from now
An analyst downgraded the pharmaceutical mainstay's shares. He now feels the company is only a hold; previously, he tagged it as worthy of a buy.

3-Stock Lunch: AMZN, WBA & LLY

04:17pm, Wednesday, 21'st Feb 2024
Boris Schlossberg, BK Asset Management managing director of FX Strategy, joins 'Power Lunch' to discuss stock plays for three stocks including; Amazon.com, Walgreens and Eli Lilly.
Analysts love growth stocks, especially those that continue to register strong earnings growth and dominate the markets in which they compete. In fact, I discuss a few of them below.
Eli Lilly is enjoying impressive revenue growth fueled by high demand for its diabetes treatments. However, the company also develops medications for cancer, plaque psoriasis, and obesity.
Top sectors are tough to pin down in advance. Far more often, we look backward at market performance to identify trends and top sectors.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE